Many components of the host-parasite interaction have been shown to affect the way viru-7 lence, that is parasite induced harm to the host, evolves. However, coevolution of multiple traits is 8 often neglected. We explore how an immunosuppressive mechanism of parasites affects and co-9 evolves with virulence through multiple infections. Applying the adaptive dynamics framework 10 to epidemiological models with coinfection, we show that immunosuppression is a double-edged-11 sword for the evolution of virulence. On one hand it amplifies the adaptive benefit of virulece by 12 increasing the abundance of coinfections through epidemiological feedbacks. On the other hand, 13 immunosuppression hinders host recovery, prolonging the duration of infection and elevating the 14 cost of killing the host. The balance between the cost and benefit of immunosuppression varies 15 across different background mortality. In addition, we find that immunosuppression evolution is 16 influenced considerably by the precise shape of the trade-offs determining the cost and benefit of 17 immunosuppression. These results demonstrate that the evolution of virulence is shaped by im-18 munosuppression, while highlighting that the evolution of immune evasion mechanisms deserves 19 further research attention. 20 The fundamental question of virulence evolution, that is, 'Why do some parasite strains harm their 22 hosts more than others?' has been a central focus of evolutionary epidemiology for both its concep-23 tual and applied significance (Ewald, 1994, Read, 1994, Schmid-Hempel, 2011, Méthot, 2012, Alizon 24 and Michalakis, 2015. The adaptive explanation of virulence is typically centred around the under-25 standing of trade-offs involving virulence and other parasite fitness components such as transmission 26 and competitiveness in multiple infections (Anderson and May, 1982, Ewald, 1983, van Baalen and 27 Sabelis, 1995, Alizon et al., 2009, 2013. While these trade-off theories explain the evolution of finite 28 non-zero optimal virulence, exactly how much virulence a parasite should evolve depends on a variety 29 of processes (Cressler et al., 2016). For example, host traits (e.g. host immune responses) and their 30 interactions with coevolving parasite adaptations (e.g. parasite immune evasion strategies; Frank and 31 -Hempel, 2008, Alizon, 2008b, Cressler et al., 2016 are likely to influence the trade-offs. The 32 present theoretical study explores how a parasite immunosuppression strategy, namely the ability of 33 parasites to hinder host recovery, coevolves with virulence.
where the subscript r denotes the resident parasite strain. In this formulation, there is a constant 89 input of susceptible hosts into the population at the rate ρ. Susceptible hosts exit the system through 90 background mortality at the rate µ while infected hosts, both singly and doubly infected individuals, 91 experience additional mortality caused by parasites (i.e. virulence α). Susceptible and singly infected 92 hosts acquire infection according to the force of infection λ r = βI r + βD rr , where β corresponds to 93 the parasite transmission rate. The host class for double infection by the same strain, D rr is included 94 in the system for a technical motivation: it is necessary for an unbiased invasion analysis because the 95 mutant strain would gain a frequency-dependent advantage in its absence (discussed in Alizon, 2008a, 96 Lipsitch et al., 2009). We assume that the rate of recovery, γ(θ), and susceptibility to coinfection, 97 σ(θ), are a function of immunosuppression, θ. Within the existing epidemiological framework, the 98 effect of host immunity can be implicitly accounted for as the rate of recovery (equivalent to the 99 rate of parasite clearance). We assume that hosts recover from infection at a rate γ(θ), in a stepwise 100 fashion, i.e. doubly infected hosts (D) only lose one infection at a time). The key feature of our 101 model is that we assume that singly infected hosts (I) suffer an increased risk of contracting a further 102 infection at a rate proportional to a coefficient σ(θ). We treat the host class D rr similarly to singly 103 infected hosts I r , except for the fact that the doubly infected hosts cannot be infected any further.
104
Within-host processes and resulting trade-offs
105
It is commonly assumed that virulence (i.e. parasite-induced host mortality) correlates with the extent of parasite resource exploitation. Adaptive benefits of resource exploitation include the positive cor-relation with transmission (Fraser et al., 2007 , de Roode et al., 2008 , Råberg, 2012 , and within-host competitive advantage in coinfection (de Roode et al., 2005 , Bell et al., 2006 , Ben-Ami et al., 2008 , Zwart et al., 2009 . Here, we focus on the latter adaptive benefit to study the evolution of virulence and immunosuppression. We assume that virulence (α) increases linearly with the level of resource exploitation by a parasite (x), such that α(x) = a x, where a is a proportionality constant (we explore a transmission-virulence trade-off in the Supplementary Information 2). We then assume that finding themselves in a doubly infected host is inherently costly for parasites due to exploitation competition between coinfecting strains (Mideo, 2009 , Schmid-Hempel, 2011 , and that more virulent strains are more competitive in multiple infections:
There is ample empirical evidence that immunosuppression benefits the parasites by prolonging 106 infections (reviewed in Schmid-Hempel, 2008), and lowered host immunity would increase the sus-
With these functions, we assume that the realised recovery rate, γ(θ), decreases as a function 119 of immunosuppression such that it equals the intensity of host immunity, γ max , in the absence of 120 immunosuppression and approaches 0 as immunosuppression approaches θ max . We also assume that 121 the proportional gain in susceptibility to a further infection, σ(θ), elevates the force of infection 122 experienced by an immunosuppressed singly infected host by up to 1 + σ range fold at the upper limit of 123 immunosuppression (when θ = θ max ). Because it is commonly assumed that the pay-off of a beneficial 124 trait saturates, we set the recovery trade-off as decelerating at default. We set the default susceptibility 125 trade-off as accelerating to further emphasise the difference between beneficial and costly traits.
126

Evolutionary analyses 127
The mutant systems 128 We carry out an invasion analysis investigating perturbation of the resident state by adding a rare mutant strain, the densities and traits of which are denoted with subscript m (Fig. 1b ). For the evolution of immunosuppression, the dynamics of the mutant strain are summarised in the following system of ODEs:
where λ r = βI r + βD rr + β rm D rm and λ m = βI m + β mr D rm . For simplicity we assume that the 129 order of infection does not matter so that D rm is identical to D mr . We neglect hosts infected twice by 130 the mutant strain (which would be D mm ) because it is unlikely that the same host gets infected twice 131 by a rare mutant. Recovery from D rm can be achieved through either clearing a resident or a mutant 132 parasite. Other aspects of demographic changes of the mutant system are identical to the resident 133 system described above. 134 We assume that the level of immunosuppression in coinfection is the average between the resident 135 and mutant strain, i.e. θ rm = θr+θm 2 . For virulence evolution, we assume that the only within-host 136 interaction between coinfecting parasites is competition for the shared host resources. Therefore, we 137 also calculate the overall virulence of coinfection as the average of the two strains, i.e. α rm = α r+ αm 2 .
138
The mutant dynamics for virulence evolution are governed by
where λ r and λ m are the force of infection for the resident and mutant, respectively, defined here 139 as βI r + βD rr + β rm D rm and βI m + β mr D rm . We again assume the trade-offs between recovery and 140 coinfection susceptibility as functions of immunosuppression in this model.
141
Adaptive dynamics
142
The fate of a rare mutant strain is determined by its fitness function (here denoted R θm and R αm , 143 respectively), that is, the ability to spread through a host population already infected with a resident 144 parasite (Geritz et al., 1998 , Dieckmann et al., 2002 . In the continuous time scale, the mutant parasite 145 invades and replaces the resident if the mutant fitness, calculated as the dominant eigenvalue of the 146 Jacobian matrix of the mutant system, is positive (Otto and Day, 2007) . The expressions for the 147 invasion fitness of a rare mutant -with respect to immunosuppression and virulence (R θm and R αm , 148 respectively) -emerging in a population infected by a resident strain are:
Consequently, an evolutionarily singular strategy can be found where the change of the invasion 150 fitness ceases with respect to the evolving trait. For example, an evolutionarily singular strategy of 151 immunosuppression (denoted θ * ) can be found when θ * is an extremum of R θm :
152
∂R θm ∂θ m θm=θr=θ * = 0.
The properties of a singular strategy can then be assessed by the second derivatives of R θm . Fol-153 lowing the notations used by Geritz et al. (1998) , here we denote the second derivatives of R θm with 154 respect to the resident and mutant strain with a and b:
The convergence stable ES (i.e. the strategy towards which selection drives the population and that 156 is also non-invasible by mutants; i.e., evolutionarily stable and convergence stable, or the continuously feedbacks: increasing virulence reduces coinfections, in which parasites reap the benefit of immunosuppression in reduced recovery without paying the cost of contracting further infections. Therefore, 189 the initial decrease in ESI with virulence is also likely mediated by the falling fraction of multiple 190 infections (Fig. 2d) . 191 We also find that the ESI increases with virulence when virulence is high enough. As the lifespan 192 of an infected host decreases due to high parasite-induced morality, it becomes unlikely for a host to varies with respect to the rate of host background mortality. We find that co-ES immunosuppression 202 (co-ESI) always decreases with host background mortality (black line in Fig. 3a ), in accord with the 203 intuition that immunosuppression represents a lost investment if the host dies too rapidly.
204
In the absence of immunosuppression, as found in previous models (van Baalen and Sabelis, (solid grey line in Fig. 3a) . Considering an extreme case in which the host never dies through back-210 ground mortality (i.e. µ = 0), the best strategy for the parasite is to evolve avirulence and maximise 211 immunosuppression so that the host remains infected forever (Fig. 3a) . This scenario can be inter-212 preted as an alignment of interest between resident and mutant strains as the benefit of keeping the 213 host alive longer appears to outweigh the adaptive advantage of being competitively dominant. With 214 zero mortality and maximum immunosuppression, a parasite's fitness is infinite: any mutant with 215 some virulence will have a finite fitness (because it will kill its host in single and double infections).
216
Intuitively, this avirulent strategy can also invade because in absence of the virulent strain, the fitness 217 is always maximised and the advantage reaped by the virulent one in coinfection is not enough to 218 overcome the cost of killing its singly-infected hosts. This cost of killing the host in single infection 219 relaxes as mortality increases, leading to a steep increase in virulence. The eventual decrease in viru-220 lence is consistent with the evolution of virulence in the absence of immunosuppression (dashed grey 221 line in Fig. 3a ) (van Baalen and Sabelis, 1995, Gandon et al., 2001) .
222
Little is known about how immunosuppression impacts host recovery and susceptibility to further 223 infection. Therefore, we also explored the sensitivity of our co-ESS results to the qualitative shape 224 of the immunosuppression trade-off and the extent of its concavity using parameters, δ σ and δ γ . We 225 find that evolution moves away from the singular strategy when the recovery concavity is highly ac-226 celerating (Fig. 4a ) meaning that in this case immunosuppression is either maximised or minimised 227 depending on the initial conditions. Furthermore, we find that immunosuppression is maximised for 228 a large area of the near-linear and decelerating recovery trade-off space, δ γ . Intermediate ESI lev-229 els are observed for highly decelerating recovery, δ γ . Overall, this suggests that there is a tendency 230 for parasites to specialise in immunosuppressing their host or to completely avoid doing so while 231 the knowledge about the recovery function appears particularly important in predicting immunosup-232 pression evolution. For virulence, the concavity of the susceptibility function (δ σ ) has the strongest 233 quantitative effect, with decelerating trade-offs leading generally to higher co-ESV. As in the rest of 234 this model, since the only benefit associated with virulence is increased competitiveness in coinfected Host immune responses present a major challenge for parasites, and hence establishing a successful That being said, considering multiple species would force us to revisit our assumption that more virulent mutants are more competitive than their resident at the within-host level. Indeed, this assumption 287 has recently been shown to hold for a variety of within-host processes but only if the mutant traits are 288 close to that of the resident (Sofonea et al. in prep) . Therefore, adding more details about the within-289 host interactions, e.g. via a nested model (Mideo et al., 2008) , seems necessary to study coinfection 290 by different species.
291
In the present model, we assumed no direct link between immunosuppression and virulence. How-292 ever, immune evasion strategies of bacteria and viruses have been empirically linked to a range of 293 pathological effects (Casadevall and Pirofski, 2003 , Monack et al., 2004 , Stanford et al., 2007 . On 294 the other hand, immunosuppression may decrease immunopathology which can therefore reduce host 295 mortality, as shown experimentally using rodent malaria infections (Long et al., 2008, Long and Gra-296 ham, 2011). In fact, helminth therapy, which involves deliberate ingestion of parasitic worms, takes 297 advantage of the parasite's ability to mediate host immunity and has been successful in countering 298 inflammations caused by immune-mediated diseases (Day et al., 2007 , Elliott and Weinstock, 2009 , 299 Summers et al., 2003 .
300
The only cost of immunosuppression we assumed is indirect (coinfection facilitation), however 301 the production of immunosuppressive compounds could impose a direct fitness cost to individual 302 pathogens. At the within-host level, immunosuppression would therefore be seen as a public good 303 since parasites that do not invest in it can still reap the benefits (Diard et al., 2013, Rundell et al., 304 2016). In fact, our model predicts that invasive repellers are common while coexistence of two strains 305 with extreme immunosuppression strategies (i.e., zero and maximum immunosuppression) is always 306 possible regardless of trade-off concavity (figure not shown). These findings suggest that it may be 307 common for some strains to specialise in immunosuppressing and others in exploiting these immuno-308 suppressed hosts.
309
Understanding how host immunity and the corresponding parasite immune evasion strategies af-310 fect virulence evolution is a key challenge for contemporary evolutionary epidemiology (Frank and off hypothesis: history, current state of affairs and the future. Journal of Evolutionary Biology Hurford, A. and T. Day, 2013. Immune evasion and the evolution of molecular mimicry in parasites. 
